MannKind | MNKD - Trade Creditors


MannKind reported $7.27M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Adma Biologics USD 24.02M 5.75M Sep/2025
BioCryst Pharmaceuticals USD 5.57M 3.02M Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
MannKind USD 7.27M 2.99M Sep/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 945K 48K Sep/2025
Novavax USD 15.23M 35.37M Sep/2025
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pfizer USD 5.02B 142M Sep/2025
Sanofi EUR 22.93B 927M Dec/2025
Xencor USD 10.83M 1.75M Dec/2025